| 000 | 01244 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517053724.0 | ||
| 264 | 0 | _c20160608 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1744-764X | ||
| 024 | 7 |
_a10.1517/14740338.2015.1093621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTashkin, D P | |
| 245 | 0 | 0 |
_aThe safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. _h[electronic resource] |
| 260 |
_bExpert opinion on drug safety _c2015 |
||
| 300 |
_a1759-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCardiotoxicity _xetiology |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIpratropium _xadministration & dosage |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 773 | 0 |
_tExpert opinion on drug safety _gvol. 14 _gno. 11 _gp. 1759-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14740338.2015.1093621 _zAvailable from publisher's website |
| 999 |
_c25291168 _d25291168 |
||